AP: Voluntary removal of popular cold-and-cough medications from store shelves fuels conspiracy theories
The University of Cincinnati's Michael Hegener recently contributed to an Associated Press fact check debunking a claim that cold medicines being pulled off of pharmacy shelves were part of a larger conspiracy.
An FDA advisory committee agreed unanimously in September that an ingredient called phenylephrine found in many over-the-counter cold medicines called phenylephrine doesn't work to clear nasal congestion when taken orally. Since then, some medicines containing phenylephrine as its only active ingredient have been removed from CVS store shelves.
Some on social media have raised suspicions that the medication removals are due to a larger conspiracy to force people to receive COVID-19 vaccinations, but Hegener and other health experts said the theory has no merit.
“While some may find the timing of this FDA advisory committee conclusion being released during the cold and flu season to be less than ideal, hopefully it prompts patients to speak with their health care providers about other options that may actually be more effective for them,” Hegener, an associate professor of pharmacy at UC's James L. Winkle College of Pharmacy, wrote to the AP.
Even as certain medications are being removed, there are still plenty of options for cough and cold medicines that contain other active ingredients that are still effective. While these medications help treat symptoms like congestion, they do not prevent illness like a flu vaccine would.
Featured photo at top of woman looking at over the counter medicine in a pharmacy aisle. Photo/iStock/SDI Productions.
Related Stories
Local 12: Pharmacies adjusting hours due to staffing issues
April 29, 2022
The University of Cincinnati's Jill Boone was featured in a Local 12 story on the impact of staffing issues at local pharmacies.
WVXU: Exploring the under-regulated dietary supplements industry
August 17, 2022
The University of Cincinnati's Michael Hegener, PharmD, was a panelist on WVXU's Cincinnati Edition discussing the under-regulated dietary supplements industry.
Drug Discovery News: Silence in healthy cells makes FOXR2 a potential cancer target
April 7, 2023
Drug Discovery News highlighted research coauthored by the University of Cincinnati's Timothy Phoenix that found a gene called FOXR2 is abnormally expressed in more than 70% of cancer types sampled and could be a potential target for new treatments.